VR Therapies for IBD
NCT: NCT07590518 · NOT_YET_RECRUITING
Brief Summary
Through a pilot randomized controlled trial (RCT), the aim is to test the clinical impact and feasibility of a AI-enhanced Virtual Reality (VR) Cognitive Behavioral therapy (CBT) program versus distraction VR among patients with inflammatory bowel disease (IBD) and anxiety. It is hypothesized that using VR/AI CBT may reduce anxiety and IBD symptoms, leading to improved overall physical, psychological, and social functioning when compared to distraction VR.
Frequently Asked Questions
What is VR Therapies for IBD?
VR Therapies for IBD is a clinical trial registered under NCT07590518. Current status: NOT_YET_RECRUITING.
What is the status of NCT07590518?
The current status of NCT07590518 (VR Therapies for IBD) is: NOT_YET_RECRUITING.
When did VR Therapies for IBD start?
VR Therapies for IBD started on 2026-06.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.